BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
2/17/17 AstraZeneca (AZN) Lynparza for Breast Cancer Subscribers Only Subscribers Only Subscribers Only
2/17/17 Celgene (CELG) Ozanimod for Multiple Sclerosis (MS) Subscribers Only Subscribers Only Subscribers Only
2/17/17 ArQule (ARQL) Tivantinib for Hepatocellular (Liver) Cancer (HCC) (Including Secondary Metastases) Subscribers Only Subscribers Only Subscribers Only
2/16/17 Sanofi (SNY) Olipudase Alfa for Niemann-Pick Disease Subscribers Only Subscribers Only Subscribers Only
2/16/17 XBiotech (XBIT) RA-18C3 for Hidradenitis Suppurativa Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
02/18/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results
02/18/17 Subscribers Only Subscribers Only Trial Data - Top-Line Results
02/18/17 Subscribers Only Subscribers Only Trial Data - Updated Results
02/18/17 Subscribers Only Subscribers Only Trial Data - Updated Results
02/18/17 Subscribers Only Subscribers Only Trial Data - Updated Results